People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sensorium Therapeutics, Inc. | — | Pharmaceuticals | Series B | $60.5M | $149.1M | 2021 |
| Cerebral Inc. | — | Other Health Care | Series B | $25.0M | $117.4M | 2025 |
Jerrold Rosenbaum at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jerrold Rosenbaum on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marc Goldberg | 1 | 9 |
| Kevin Lalande | 1 | 8 |
| Alexandra Glucksmann | 1 | 4 |
| Ryan Katz | 1 | 4 |
| David Southwell | 1 | 3 |
| Balkrishan Gill | 1 | 3 |
| Richard Hamilton | 1 | 2 |
| Brian Reinken | 1 | 2 |
| Jacqueline Kniska | 1 | 1 |
| Richard Simon | 1 | 1 |
| Ranga Krishnan | 1 | 1 |
| Jacob Hooker | 1 | 1 |
| Pranav Tadi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.